Katie and Eszter’s paper on ultra-sensitive measurement of POLYGP for clinical trial use is out!  

By 18/07/2022July 14th, 2023Uncategorized

We developed an ultra-sensitive Simoa-based immunoassay for detecting C9orf72 polyGP in CSF. In collaboration with Wave Life Sciences we validated the assay for clinical trial use and validated it using samples from the Genetic FTD Initiative.  A great collaboration with Henrik Zetterberg, Amanda Heslegrave, Jon Rohrer and Wave.